About

Dr. Stephen R. Quake has served on AbCellera's Board of Directors since November 2025 and is a member of the Audit Committee and the Nominating and Corporate Governance Committee. He has been a professor at Stanford University since 2005, where he is the Lee Otterson Professor of Bioengineering and Professor of Applied Physics, and is a prolific inventor in DNA sequencing and microfluidic automation whose work contributed to non-invasive prenatal testing. He serves on the boards of Tachyon Therapeutics, IgGenix, Superfluid DX, ClearNote Health, Kanvas and Mirvie. He holds a B.S. in Physics and an M.S. in Mathematics from Stanford University and a D.Phil. in Theoretical Physics from the University of Oxford.

Roles

AbCellera Biologics Inc.
Director · Current role
November 2025–present
Stanford University
Lee Otterson Professor of Bioengineering and Professor of Applied Physics
2005 - present
CM Life Sciences II / SomaLogic
Director
2020 - 2022

External Roles

Tachyon Therapeutics
Director
IgGenix Inc.
Director
Mirvie
Director
ClearNote Health
Director

Director Compensation

FY 2025
Fees earned or paid in cash
$10,575
ComponentBoard and committee cash retainers, prorated for FY2025 service
Option awards
$426,916
ComponentAnnual stock option grant, ASC 718 grant-date fair value
Total
$437,491
NoteAppointed to the Board November 6, 2025; compensation prorated and includes the new-director equity grant

Also at AbCellera Biologics Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

You're subscribed.

Thanks for signing up.